Cargando…
Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure
The heart has a reduced capacity to generate sufficient energy when failing, resulting in an energy-starved condition with diminished functions. Studies have identified numerous changes in metabolic pathways in the failing heart that result in reduced oxidation of both glucose and fatty acid substra...
Autor principal: | Perez, Dianne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198887/ https://www.ncbi.nlm.nih.gov/pubmed/34071350 http://dx.doi.org/10.3390/ijms22115783 |
Ejemplares similares
-
α(1)-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer’s Disease
por: Perez, Dianne M.
Publicado: (2023) -
Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling
por: Femminella, Grazia Daniela, et al.
Publicado: (2014) -
Beta-adrenergic receptor antagonists and chronic heart failure in children
por: Filippo, Sylvie Di
Publicado: (2007) -
β-Adrenergic receptor signaling in cardiac function and heart failure
por: Madamanchi, Aasakiran
Publicado: (2007) -
Current Developments on the Role of α(1)-Adrenergic Receptors in Cognition, Cardioprotection, and Metabolism
por: Perez, Dianne M.
Publicado: (2021)